[1] 王安伟,罗素新,向睿.266例冠心病患者经皮冠状动脉介入治疗的临床分析[J].重庆医学,2010,39(12):1582~1583. [2] French JK, Burgess S and Chew DP: Re-infarction after primary percutaneous coronary intervention[J].Current opinion in cardiology,2015,30:354~358. [3] 张赫男,李曦铭,胡越成,等.冠心病伴2型糖尿病患者PCI预后分析[J].天津医药,2013,41(1):29~32. [4] Forst T, Hohberg C, Pfützner A. Cardiovascular effects of disturbedinsulin activity in metabolic syndrome and in type 2 diabeticpatients[J].Horm Metab Res, 2009,41(2):123~131. [5] Naito M.effects of fibrinogen,fibrin and their degradation productson the behaviour of vascular smooth muscle cells[J].Nihon RonenIgakkai Zasshi,2000,37( 6) : 458~463. [6] Ndrepepa G,Braun S,King L,et al. Relation of fibrinogen levelwith cardiovascular events in patients with coronary artery disease[J].Clin Sci ( Lond) ,2013,111( 6) : 804~810. [7] 李若铭,曾奕芝.微信群在中青年冠状动脉介入术患者出院后戒烟干预中的应用[J].中国临床护理,2014,6(5):389~391.
2018, Vol. 24 
冀公网安备13080202000677号